Aimee O. Hersh
Rating: 4.9 of 5
( out of 31 reviews )

Aimee O. Hersh, MD

Languages spoken: English, Spanish

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Layton Parkway Clinic

Primary Children's Hospital Outpatient Services at Layton Hospital, Pediatric Rheumatology
201 W Layton Pkwy
Layton , UT 84041
801-213-3599
Get Directions

  • Dr. Aimee Hersh received her medical degree from Brown Medical School and completed her residency and clinical fellowship in Pediatric Rheumatology at University of California, San Francisco. She is currently an Associate Professor in Pediatric Rheumatology and Division Chief of Pediatric Rheumatology at the University of Utah School of Medicine and Primary Children’s Hospital. She is an elected member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Steering Committee and Chair of the Lupus Committee. Her research focuses on understanding the long-term medical and psychosocial outcomes of patients with childhood-onset systemic lupus erythematosus and juvenile idiopathic arthritis.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Peds Rheumatology)

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 31 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    October 17, 2024
    EXTERNAL SITE
    Rating: 4 out of 5

    Dr hersh is a wonderful Dr.

  • Dr. Aimee Hersh received her medical degree from Brown Medical School and completed her residency and clinical fellowship in Pediatric Rheumatology at University of California, San Francisco. She is currently an Associate Professor in Pediatric Rheumatology and Division Chief of Pediatric Rheumatology at the University of Utah School of Medicine and Primary Children’s Hospital. She is an elected member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Steering Committee and Chair of the Lupus Committee. Her research focuses on understanding the long-term medical and psychosocial outcomes of patients with childhood-onset systemic lupus erythematosus and juvenile idiopathic arthritis.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Professor
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Peds Rheumatology)

    Education history

    Fellowship Rheumatology - University of California, San Francisco Fellow
    Residency Pediatrics - University of California, San Francisco Resident
    Graduate Training Clinical Epidemiology - Dartmouth College M.S.
    Professional Medical Medicine - Brown Medical School M.D.
    Undergraduate Spanish - Whitman College B.A.

    Selected Publications

    Journal Article

    1. Sammaritano LR, Askanase A, Bermas BL, DallEra M, Duarte-Garca A, Hiraki LT, Son MBF, Werth VP, Aranow C, Barnado A, Broder A, Brunner HI, Chong BF, Chowdhary VR, Hersh AO, Izmirly PM, Jules M, Kalunian K, Kamen D, Rubinstein TB, Smith BJ, Smith NM, Thomas A, Timlin H, Wallace DJ, Azzam M, Bartels CM, Cunha JS, DeQuattro K, Fava A, Figueroa-Parra G, Garg S, Gomes LLA, Cullar-Gutirrez MC, Iyer P, Johannemann AS, Jorge A, Kasturi S, Kawtharany H, Khawandi J, Legge A, Liang KP, Lockwood MM, Sanchez-Rodriguez A, Turgunbaev M, Williams JN, Turner AS, Mustafa RA (2025). 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus. Arthritis Rheumatol. (Read full publication)
    2. Sammaritano LR, Askanase A, Bermas BL, DallEra M, Duarte-Garca A, Hiraki LT, Son MBF, Werth VP, Aranow C, Barnado A, Broder A, Brunner HI, Chong BF, Chowdhary VR, Hersh AO, Izmirly PM, Jules M, Kalunian K, Kamen D, Rubinstein TB, Smith BJ, Smith NM, Thomas A, Timlin H, Wallace DJ, Azzam M, Bartels CM, Cunha JS, DeQuattro K, Fava A, Figueroa-Parra G, Garg S, Gomes LLA, Cullar-Gutirrez MC, Iyer P, Johannemann AS, Jorge A, Kasturi S, Kawtharany H, Khawandi J, Legge A, Liang KP, Lockwood MM, Sanchez-Rodriguez A, Turgunbaev M, Williams JN, Turner AS, Mustafa RA (2025). 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). (Read full publication)
    3. Case S, Hill CL, Shrader P, Dennos A, Phillips T, Schanberg LE, von Scheven E, Barbour K, Knight AM, Hersh A, Son M, CARRA Registry Investigators (2025). Disease activity trajectories in paediatric lupus and associations with socioeconomic factors and patient-reported pain. Lupus Sci Med, 12(2). (Read full publication)
    4. Sammaritano LR, Askanase A, Bermas BL, DallEra M, Duarte-Garca A, Hiraki LT, Rovin BH, Son MBF, Alvarado A, Aranow C, Barnado A, Broder A, Brunner HI, Chowdhary V, Contreras G, Felix C, Ferucci ED, Gibson KL, Hersh AO, Izmirly PM, Kalunian K, Kamen D, Rollins B, Smith BJ, Thomas A, Timlin H, Wallace DJ, Ward M, Azzam M, Bartels CM, Cunha JS, DeQuattro K, Fava A, Figueroa-Parra G, Garg S, Greco J, Cullar-Gutirrez MC, Iyer P, Johannemann AS, Jorge A, Kasturi S, Kawtharany H, Khawandi J, Kirou KA, Legge A, Liang KV, Lockwood MM, Sanchez-Rodriguez A, Turgunbaev M, Williams JN, Turner AS, Mustafa RA (2025). 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Rheumatol. (Read full publication)
    5. Sammaritano LR, Askanase A, Bermas BL, DallEra M, Duarte-Garca A, Hiraki LT, Rovin BH, Son MBF, Alvarado A, Aranow C, Barnado A, Broder A, Brunner HI, Chowdhary V, Contreras G, Felix C, Ferucci ED, Gibson KL, Hersh AO, Izmirly PM, Kalunian K, Kamen D, Rollins B, Smith BJ, Thomas A, Timlin H, Wallace DJ, Ward M, Azzam M, Bartels CM, Cunha JS, DeQuattro K, Fava A, Figueroa-Parra G, Garg S, Greco J, Cullar-Gutirrez MC, Iyer P, Johannemann AS, Jorge A, Kasturi S, Kawtharany H, Khawandi J, Kirou KA, Legge A, Liang KV, Lockwood MM, Sanchez-Rodriguez A, Turgunbaev M, Williams JN, Turner AS, Mustafa RA (2025). 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Care Res (Hoboken). (Read full publication)
    6. Sadun RE, Cooper JC, Belot A, Avcin T, Aggarwal A, Ainsworth J, Akinsete A, Ardoin SP, Beresford MW, Bortey L, Brunner HI, Chang JC, Ciurtin C, Daftary A, Eberhard B, Feldman CH, Hedrich CM, Hersh AO, Hiraki LT, Isenberg DA, Kamphuis S, Knight AM, Lambert L, Levy DM, Marks SD, Maxwell N, Migowa A, Moore K, Ozen S, Ramsey-Goldman R, Ravelli A, Reeve BB, Rubinstein TB, Saad-Magalhaes C, Sawhney S, Schanberg LE, von Scheven E, Scott C, Son MB, Tony G, Weitzman ER, Wenderfer SE, Woodside A, Lewandowski LB, Smith EM, CARRA SLE Committee and PReS Lupus Working Party (2025). Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. Ann Rheum Dis, 84(2), 158-168. (Read full publication)
    7. Overbury RS, Eddington D, Sward K, Hersh A (2025). Patient and parent perspectives on an academic rheumatology transition clinic. Health Care Transit, 3, 100094. (Read full publication)
    8. Soulsby WD, Olveda R, He J, Berbert L, Weller E, Barbour KE, Greenlund KJ, Schanberg LE, von Scheven E, Hersh A, Son MBF, Chang J, Knight A, CARRA Registry Investigators (2024). Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study. Arthritis Care Res (Hoboken), 77(1), 38-49. (Read full publication)
    9. Avery CN, Russell ND, Steely CJ, Hersh AO, Bohnsack JF, Prahalad S, Jorde LB (2024). Shared genomic segments analysis identifies MHC class I and class III molecules as genetic risk factors for juvenile idiopathic arthritis. HGG Adv, 5(2), 100277. (Read full publication)
    10. Sagcal-Gironella ACP, Merritt A, Mizuno T, Dharnidharka VR, McDonald J, DeGuzman M, Wahezi D, Goilav B, Onel K, Kim S, Cody E, Wu EY, Cannon L, Hayward K, Okamura DM, Patel PN, Greenbaum LA, Rouster-Stevens KA, Cooper JC, Ruth NM, Ardoin S, Cook K, Borgia RE, Hersh A, Huang B, Devarajan P, Brunner H (2024). Efficacy and Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis-A Double-Blind Placebo Controlled Clinical Trial (The Pediatric Lupus Nephritis Mycophenolate Mofetil Study). J Clin Trials, 14(4). (Read full publication)
    11. Kohli AT, Hersh AO, Ponder L, Chan LHK, Rouster-Stevens KA, Tebo AE, Kugathasan S, Guthery SL, Bohnsack JF, Prahalad S (2023). Prevalence of tissue transglutaminase antibodies and IgA deficiency are not increased in juvenile idiopathic arthritis: a case-control study. Pediatr Rheumatol Online J, 21(1), 110. (Read full publication)
    12. Huang Y, Sompii-Montgomery L, Patti J, Pickering A, Yasin S, Do T, Baker E, Gao D, Abdul-Aziz R, Behrens EM, Canna S, Clark M, Co DO, Collins KP, Eberhard B, Friedman M, Graham TB, Hahn T, Hersh AO, Hobday P, Holland MJ, Huggins J, Lu PY, Mannion ML, Manos CK, Neely J, Onel K, Orandi AB, Ramirez A, Reinhardt A, Riskalla M, Santiago L, Stoll ML, Ting T, Grom AA, Towe C, Schulert GS (2023). Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. Arthritis Care Res (Hoboken). (Read full publication)
    13. Smitherman EA, Chahine RA, Beukelman T, Lewandowski LB, Rahman AKMF, Wenderfer SE, Curtis JR, Hersh AO, CARRA Registry Investigators (2023). Childhood-Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-Term Kidney Status and Variation in Care. Arthritis Care Res (Hoboken), 75(7), 1553-1562. (Read full publication)
    14. Melega S, Brogan P, Cleary G, Hersh AO, Kasapcopur O, Rangaraj S, Yeung RSM, Zeft A, Cooper J, Pordeli P, Kirchner P, Lehane PB (2022). Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis. Rheumatol Ther, 9(2), 721-734. (Read full publication)
    15. Cannon L, Caliendo A, Hersh A, Knight AM (2022). "There's so much to be done": a qualitative study to elucidate research priorities in childhood-onset systemic lupus erythematosus. Lupus Sci Med, 9(1). (Read full publication)
    16. Cannon L, Wenderfer SE, Lewandowski LB, Cooper JC, Goilav B, Knight AM, Hersh AO, Ardoin SP, Sadun RE, CARRA Lupus Nephritis Workgroup (2022). Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-onset Systemic Lupus Erythematosus in North America. J Rheumatol, 49, 607-614. (Read full publication)
    17. Johnson KR, Edens C, Sadun RE, Chira P, Hersh AO, Goh YI, Hui-Yuen J, Singer NG, Spiegel LR, Stinson JN, White PH, Lawson E, CARRA Transition Workgroup (2021). Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Clinicians From 2010 to 2018. J Rheumatol, 48(9), 1442-1449.
    18. Vazzana KM, Daga A, Goilav B, Ogbu EA, Okamura DM, Park C, Sadun RE, Smitherman EA, Stotter BR, Dasgupta A, Knight AM, Hersh AO, Wenderfer SE, Lewandowski LB, CARRA Registry investigators (2021). Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort. Lupus, 30(10), 1660-1670. (Read full publication)
    19. Fawole OA, Reed MV, Harris JG, Hersh A, Rodriguez M, Onel K, Lawson E, Rubinstein T, Ardalan K, Morgan E, Paul A, Barlin J, Daly RP, Dave M, Malloy S, Hume S, Schrandt S, Marrow L, Chapson A, Napoli D, Napoli M, Moyer M, Delgaizo V, Danguecan A, von Scheven E, Knight A, CARRA Investigators (2021). Engaging patients and parents to improve mental health intervention for youth with rheumatological disease. Pediatr Rheumatol Online J, 19(1), 19. (Read full publication)
    20. Feldman CH, Speyer C, Ashby R, L Bermas B, Bhattacharyya S, Chakravarty E, Everett B, Ferucci E, Hersh AO, Marty FM, Merola JF, Ramsey-Goldman R, Rovin BH, Son MB, Tarter L, Waikar S, Yazdany J, Weissman JS, Costenbader KH (2019). Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. Arthritis Care Res (Hoboken), 73(1), 146-157. (Read full publication)
    21. Haro SL, Lawson EF, Hersh AO (2020). Disease activity and health-care utilization among young adults with childhood-onset lupus transitioning to adult care: data from the Pediatric Lupus Outcomes Study. Lupus, 29(10), 1206-1215. (Read full publication)
    22. Ardoin SP, Daly RP, Merzoug L, Tse K, Ardalan K, Arkin L, Knight A, Rubinstein T, Ruth N, Wenderfer SE, Hersh AO, Childhood Arthritis and Rheumatology Research Alliance and Lupus Foundation of America (2019). Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise. Pediatr Rheumatol Online J, 17(1), 32. (Read full publication)
    23. Ravindra VM, Mazur MD, Mohila CA, Sweney MT, Hersh A, Bollo RJ (2015). Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review. Childs Nerv Syst, 31(11), 2165-71. (Read full publication)
    24. Bennett TD, Fluchel M, Hersh AO, Hayward KN, Hersh AL, Brogan TV, Srivastava R, Stone BL, Korgenski EK, Mundorff MB, Casper TC, Bratton SL (2012). Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum, 64(12), 4135-42. (Read full publication)
    25. Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N, Hsu J, Klein-Gitelman M, Moorthy LN, Muscal E, Radhakrishna SM, Wagner-Weiner L, Adams M, Blier P, Buckley L, Chalom E, Chedeville G, Eichenfield A, Fish N, Henrickson M, Hersh AO, Hollister R, Jones O, Jung L, Levy D, Lopez-Benitez J, McCurdy D, Miettunen PM, Quintero-del Rio AI, Rothman D, Rullo O, Ruth N, Schanberg LE, Silverman E, Singer NG, Soep J, Syed R, Vogler LB, Yalcindag A, Yildirim-Toruner C, Wallace CA, Brunner HI (2012). Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken), 64(3), 375-83. (Read full publication)
    26. Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, Katz P, Criswell LA, Yelin E (2009). Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum, 61(1), 13-20. (Read full publication)

  • News & Podcasts

    News